(Q42947767)

11 November 2017

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor (English)

1 reference

11 November 2017

2

Christophe Hézode

0 references

author name string

Florence Beckerich

1

1 reference

11 November 2017

Christophe Hézode

2

1 reference

11 November 2017

Christine Robin

3

1 reference

11 November 2017

Jean-Louis Beaumont

4

1 reference

11 November 2017

Eric Gautier

5

1 reference

11 November 2017

Sébastien Maury

6

1 reference

11 November 2017

Catherine Cordonnier

7

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 October 2014

1 reference

11 November 2017

1 reference

11 November 2017

124

1 reference

11 November 2017

16

1 reference

11 November 2017

2613-2614

1 reference

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

Long-term outcome of hepatitis C infection after bone marrow transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199962

10.1182/BLOOD-2014-06-582122

1 December 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

25323689

1 reference